Surgepays Book Value Per Share from 2010 to 2024
SURG Stock | USD 4.00 0.08 2.04% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 1.9812652 | Current Value 3.96 | Quarterly Volatility 18.56852999 |
Check Surgepays financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgepays main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1.1 M or Selling General Administrative of 16.3 M, as well as many exotic indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0 or PTB Ratio of 3.42. Surgepays financial statements analysis is a perfect complement when working with Surgepays Valuation or Volatility modules.
Surgepays | Book Value Per Share |
Latest Surgepays' Book Value Per Share Growth Pattern
Below is the plot of the Book Value Per Share of Surgepays over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Surgepays' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgepays' overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 1.96 X | 10 Years Trend |
|
Book Value Per Share |
Timeline |
Surgepays Book Value Per Share Regression Statistics
Arithmetic Mean | (10.17) | |
Geometric Mean | 2.69 | |
Coefficient Of Variation | (182.65) | |
Mean Deviation | 14.36 | |
Median | (1.22) | |
Standard Deviation | 18.57 | |
Sample Variance | 344.79 | |
Range | 51.2644 | |
R-Value | 0.68 | |
Mean Square Error | 200.48 | |
R-Squared | 0.46 | |
Significance | 0.01 | |
Slope | 2.82 | |
Total Sum of Squares | 4,827 |
Surgepays Book Value Per Share History
Other Fundumenentals of Surgepays
Surgepays Book Value Per Share component correlations
Click cells to compare fundamentals
About Surgepays Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Surgepays income statement, its balance sheet, and the statement of cash flows. Surgepays investors use historical funamental indicators, such as Surgepays's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Surgepays investors may use each financial statement separately, they are all related. The changes in Surgepays's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Surgepays's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Surgepays Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Surgepays. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.98 | 3.96 | |
Tangible Book Value Per Share | 1.69 | 3.06 |
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out the analysis of Surgepays Correlation against competitors. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.38 | Revenue Per Share 9.618 | Quarterly Revenue Growth (0.11) | Return On Assets 0.3106 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.